59 related articles for article (PubMed ID: 526738)
1. Trimethoquinol selectively antagonises longitudinal muscle contractions of rat isolated gastric fundus to thromboxane B2 and epoxymethano analogues of PGH2 [proceedings].
Bennett A; Sanger GJ
Br J Pharmacol; 1979 Jul; 66(3):450P. PubMed ID: 526738
[No Abstract] [Full Text] [Related]
2. Trimethoquinol selectively antagonizes contractions of rat gastric fundus to TXB2 and epoxymethano analogs of PGH2.
Sanger GJ; Bennett A
Adv Prostaglandin Thromboxane Res; 1980; 8():1559-60. PubMed ID: 6103666
[No Abstract] [Full Text] [Related]
3. Effects of the prostaglandin H2/thromboxane A2 antagonist BM 13.177 on human platelets.
Patscheke H; Stegmeier K
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():371-3. PubMed ID: 3159225
[No Abstract] [Full Text] [Related]
4. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
Mukhopadhyay A; Navran SS; Amin HM; Abdel-Aziz SA; Chang J; Sober DJ; Miller DD; Feller DR
J Pharmacol Exp Ther; 1985 Jan; 232(1):1-9. PubMed ID: 3855323
[TBL] [Abstract][Full Text] [Related]
5. Trimethoquinol is a potent prostaglandin endoperoxide antagonist [proceedings].
MacIntyre DE; Willis AL
Br J Pharmacol; 1978 Jun; 63(2):361P. PubMed ID: 667443
[No Abstract] [Full Text] [Related]
6. Antagonism of thromboxane A2/prostaglandin H2 by 13-azaprostanoic acid prevents platelet deposition to the de-endothelialized rabbit aorta in vivo.
Le Breton GC; Lipowski JP; Feinberg H; Venton DL; Ho T; Wu KK
J Pharmacol Exp Ther; 1984 Apr; 229(1):80-4. PubMed ID: 6423815
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of prostanoid-induced contractions of rat gastric fundus muscle by SC-19220, sodium meclofenamate, indomethacin or trimethoquinol.
Bennett A; Jarosik C; Sanger GJ; Wilson DE
Br J Pharmacol; 1980; 71(1):169-75. PubMed ID: 6110453
[TBL] [Abstract][Full Text] [Related]
8. Biosynthesis and biological properties of prostaglandin endoperoxides and thromboxane A2.
Svensson J
Acta Biol Med Ger; 1978; 37(5-6):731-40. PubMed ID: 742285
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro pharmacology of 7-oxabicyclo[2.2.1]heptane analogues of thromboxane A2/PGH2.
Sprague PW; Heikes JE; Gougoutas JZ; Malley MF; Harris DN; Greenberg R
J Med Chem; 1985 Nov; 28(11):1580-90. PubMed ID: 4067988
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the actions of 11.9 epoxymethano PGH2 and 9.11 azo PGH2 on rat aorta and stomach strip preparations.
McGlynn S; Mallarkey G; Smith GM
Prostaglandins; 1984 Jan; 27(1):105-10. PubMed ID: 6709935
[TBL] [Abstract][Full Text] [Related]
11. A 16-p-fluorophenoxy prostanoid with potent and long-lasting thromboxane-like actions [proceedings].
Jones RL; Wilson NH
Br J Pharmacol; 1978 Jun; 63(2):362P. PubMed ID: 667444
[No Abstract] [Full Text] [Related]
12. Prostaglandin H2 in human platelet activation: coactivator and substitute for thromboxane A2.
Hornberger WB; Patscheke H
Prog Clin Biol Res; 1989; 301():315-9. PubMed ID: 2798452
[TBL] [Abstract][Full Text] [Related]
13. 9,11-epoxyiminoprosta-5,13-dienoic acid is a thromboxane A2 antagonist in human platelets.
Fitzpatrick FA; Bundy GL; Gorman RR; Honohan T
Nature; 1978 Oct; 275(5682):764-6. PubMed ID: 703845
[No Abstract] [Full Text] [Related]
14. Stereoselective inhibition of prostaglandin-induced calcium release from platelet membranes by trimetoquinol.
Mayo JR; Miller DD; Feller DR
Biochem Pharmacol; 1983 Jun; 32(12):1952-5. PubMed ID: 6882470
[No Abstract] [Full Text] [Related]
15. The use of synthetic thromboxane A2 (TXA2-S) and a new class of thromboxane antagonists, indole-2-propanoic acids to characterize the thromboxane receptor.
Gillard JW; Morton HE; Fortin R; Yoakim C; Girard Y; Lord A; Ethier D; Leveille C; Letts G; Evans J
Prog Clin Biol Res; 1989; 301():579-83. PubMed ID: 2529557
[No Abstract] [Full Text] [Related]
16. Pathophysiological role of thromboxane A2 and pharmacological approaches to its inhibition.
Patscheke H; Hornberger W; Zehender H
Z Kardiol; 1990; 79 Suppl 3():151-4. PubMed ID: 2099038
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of PGH2 in the feline brain.
Bishai I; Coceani F
Adv Prostaglandin Thromboxane Res; 1980; 8():1221-3. PubMed ID: 7376980
[No Abstract] [Full Text] [Related]
18. Antagonism of thromboxane receptor induced contractions in isolated human groin lymphatics.
Sjöberg T; Andersson KE; Norgren L; Steen S
Lymphology; 1989 Sep; 22(3):135-40. PubMed ID: 2532276
[TBL] [Abstract][Full Text] [Related]
19. Partial agonism of prostaglandin H2 analogs and 11-deoxy-prostaglandin F2 alpha to thromboxane-sensitive preparations.
Jones RL; Wilson NH
Adv Prostaglandin Thromboxane Res; 1980; 6():467-75. PubMed ID: 7386280
[No Abstract] [Full Text] [Related]
20. Platelet thromboxane A2/endoperoxide (TXA2/PGH2) receptors in type I diabetes mellitus.
Jaschonek K; Faul C; Weisenberger H; Krönert K; Schröder H; Renn W
Thromb Haemost; 1989 Jun; 61(3):535-6. PubMed ID: 2529665
[No Abstract] [Full Text] [Related]
[Next] [New Search]
